| 51 |
34248355 | In Silico Exploration of Phytoconstituents From Phyllanthus emblica and Aegle marmelos as Potential Therapeutics Against SARS-CoV-2 RdRp. | 2021 |
2 |
| 52 |
34282419 | Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase. | 2021 Jul 27 |
2 |
| 53 |
34305617 | Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations. | 2021 |
6 |
| 54 |
34315339 | Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase. | 2021 Jul 27 |
1 |
| 55 |
34339634 | "Bucket brigade" using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2. | 2021 Sep 7 |
2 |
| 56 |
34440200 | SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System. | 2021 Aug 11 |
2 |
| 57 |
34490343 | Molecular Dynamics Simulations Reveal the Interaction Fingerprint of Remdesivir Triphosphate Pivotal in Allosteric Regulation of SARS-CoV-2 RdRp. | 2021 |
3 |
| 58 |
34517419 | Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir. | 2021 Oct |
1 |
| 59 |
34533107 | Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies. | 2021 Sep 17 |
1 |
| 60 |
34543728 | Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors. | 2021 Dec 1 |
1 |
| 61 |
34613689 | Reductionism Ad Absurdum: The Misadventures of Structural Biology in the Time of Coronavirus. | 2021 Nov 12 |
1 |
| 62 |
34632942 | In silico identification of novel benzophenone-coumarin derivatives as SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitors. | 2021 Oct 11 |
1 |
| 63 |
34637693 | Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches. | 2021 Oct 12 |
4 |
| 64 |
34641337 | Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors. | 2021 Sep 24 |
1 |
| 65 |
34642689 | Potent and Selective Covalent Inhibitors of the Papain-like Protease from SARS-CoV-2. | 2021 Oct 8 |
1 |
| 66 |
34653416 | Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex. | 2021 Oct 26 |
2 |
| 67 |
34717229 | Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach. | 2021 Dec |
2 |
| 68 |
34746476 | Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs. | 2021 Nov |
2 |
| 69 |
34829734 | Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach. | 2021 Oct 20 |
1 |
| 70 |
34850656 | Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2. | 2021 Dec 1 |
1 |
| 71 |
34873274 | Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models. | 2021 Dec 6 |
1 |
| 72 |
34946521 | Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp). | 2021 Dec 8 |
1 |
| 73 |
32222463 | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. | 2020 Jul 15 |
2 |
| 74 |
32277040 | Structure of the RNA-dependent RNA polymerase from COVID-19 virus. | 2020 May 15 |
1 |
| 75 |
32283108 | Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. | 2020 Jun |
2 |
| 76 |
32284326 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. | 2020 May 15 |
6 |
| 77 |
32358203 | Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. | 2020 Jun 26 |
3 |
| 78 |
32511290 | Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins. | 2020 Apr 8 |
1 |
| 79 |
32517353 | Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. | 2020 Jun 7 |
1 |
| 80 |
32521159 | Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase. | 2020 Aug 13 |
7 |
| 81 |
32563812 | A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. | 2020 Sep 1 |
1 |
| 82 |
32702590 | Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation. | 2020 Nov |
1 |
| 83 |
32754599 | nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. | 2020 |
1 |
| 84 |
32887884 | Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. | 2020 Sep 4 |
1 |
| 85 |
32947136 | Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. | 2020 Nov |
1 |
| 86 |
32967965 | Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. | 2020 Nov 20 |
3 |
| 87 |
33100032 | Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV. | 2020 Nov |
9 |
| 88 |
33102688 | In silico identification of drug candidates against COVID-19. | 2020 |
1 |
| 89 |
33185784 | Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment. | 2020 Dec |
2 |
| 90 |
33190493 | Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. | 2020 Nov 25 |
3 |
| 91 |
33264025 | Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations. | 2020 Dec 17 |
5 |
| 92 |
33283177 | Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase. | 2020 Dec 18 |
1 |
| 93 |
33287144 | Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. | 2020 Dec 3 |
1 |
| 94 |
33305304 | Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy. | 2020 Dec 23 |
1 |